These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 31277978)

  • 1. CRISPR-based functional evaluation of schizophrenia risk variants.
    Rajarajan P; Flaherty E; Akbarian S; Brennand KJ
    Schizophr Res; 2020 Mar; 217():26-36. PubMed ID: 31277978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration of CRISPR-engineering and hiPSC-based models of psychiatric genomics.
    Matos MR; Ho SM; Schrode N; Brennand KJ
    Mol Cell Neurosci; 2020 Sep; 107():103532. PubMed ID: 32712198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applying stem cells and CRISPR engineering to uncover the etiology of schizophrenia.
    Michael Deans PJ; Brennand KJ
    Curr Opin Neurobiol; 2021 Aug; 69():193-201. PubMed ID: 34010781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling common and rare genetic risk factors of neuropsychiatric disorders in human induced pluripotent stem cells.
    Muhtaseb AW; Duan J
    Schizophr Res; 2022 Apr; ():. PubMed ID: 35459617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling the complex genetic architectures of brain disease.
    Fernando MB; Ahfeldt T; Brennand KJ
    Nat Genet; 2020 Apr; 52(4):363-369. PubMed ID: 32203467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating CRISPR Engineering and hiPSC-Derived 2D Disease Modeling Systems.
    Rehbach K; Fernando MB; Brennand KJ
    J Neurosci; 2020 Feb; 40(6):1176-1185. PubMed ID: 32024766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous Cell Type-Specific Disrupted in Schizophrenia 1 Interactomes Reveal Protein Networks Associated With Neurodevelopmental Disorders.
    Wilkinson B; Evgrafov OV; Zheng D; Hartel N; Knowles JA; Graham NA; Ichida JK; Coba MP
    Biol Psychiatry; 2019 Feb; 85(4):305-316. PubMed ID: 29961565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR/Cas9 Genome Editing: A Promising Tool for Therapeutic Applications of Induced Pluripotent Stem Cells.
    Zhang Y; Sastre D; Wang F
    Curr Stem Cell Res Ther; 2018; 13(4):243-251. PubMed ID: 29446747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-independent human induced pluripotent stem cell model: A new tool for rapid determination of genetic variant pathogenicity in long QT syndrome.
    Chavali NV; Kryshtal DO; Parikh SS; Wang L; Glazer AM; Blackwell DJ; Kroncke BM; Shoemaker MB; Knollmann BC
    Heart Rhythm; 2019 Nov; 16(11):1686-1695. PubMed ID: 31004778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deciphering pathogenicity of variants of uncertain significance with CRISPR-edited iPSCs.
    Guo H; Liu L; Nishiga M; Cong L; Wu JC
    Trends Genet; 2021 Dec; 37(12):1109-1123. PubMed ID: 34509299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
    Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New considerations for hiPSC-based models of neuropsychiatric disorders.
    Hoffman GE; Schrode N; Flaherty E; Brennand KJ
    Mol Psychiatry; 2019 Jan; 24(1):49-66. PubMed ID: 29483625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of Schizophrenia with Human Induced Pluripotent Stem Cells.
    Powell SK; O'Shea CP; Shannon SR; Akbarian S; Brennand KJ
    Adv Neurobiol; 2020; 25():155-206. PubMed ID: 32578147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells.
    Kim EJ; Kang KH; Ju JH
    Korean J Intern Med; 2017 Jan; 32(1):42-61. PubMed ID: 28049282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of CRISPR/Cas associated technologies for cell transplant applications.
    Cowan PJ
    Curr Opin Organ Transplant; 2016 Oct; 21(5):461-6. PubMed ID: 27517504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human induced pluripotent stem cell line with genetically encoded fluorescent voltage indicator generated via CRISPR for action potential assessment post-cardiogenesis.
    Sun YH; Kao HKJ; Chang CW; Merleev A; Overton JL; Pretto D; Yechikov S; Maverakis E; Chiamvimonvat N; Chan JW; Lieu DK
    Stem Cells; 2020 Jan; 38(1):90-101. PubMed ID: 31566285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem Cell Models for Context-Specific Modeling in Psychiatric Disorders.
    Seah C; Huckins LM; Brennand KJ
    Biol Psychiatry; 2023 Apr; 93(7):642-650. PubMed ID: 36658083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The iCRISPR platform for rapid genome editing in human pluripotent stem cells.
    Zhu Z; González F; Huangfu D
    Methods Enzymol; 2014; 546():215-50. PubMed ID: 25398343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional signatures of schizophrenia in hiPSC-derived NPCs and neurons are concordant with post-mortem adult brains.
    Hoffman GE; Hartley BJ; Flaherty E; Ladran I; Gochman P; Ruderfer DM; Stahl EA; Rapoport J; Sklar P; Brennand KJ
    Nat Commun; 2017 Dec; 8(1):2225. PubMed ID: 29263384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR/Cas9 gene-editing strategies in cardiovascular cells.
    Vermersch E; Jouve C; Hulot JS
    Cardiovasc Res; 2020 Apr; 116(5):894-907. PubMed ID: 31584620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.